White matter micro- and macrostructure brain charts for the human lifespan
Michael E. Kim, Chenyu Gao, Karthik Ramadass, Nancy R. Newlin, Praitayini Kanakaraj, Sam Bogdanov, Gaurav Rudravaram, Derek Archer, Timothy J. Hohman, Angela L. Jefferson, Victoria L. Morgan, Alexandra Roche, Dario J. Englot, Susan M. Resnick, Lori L. Beason Held, Laurie E. Cutting, Laura A. Barquero, Micah A. D’archangel, Tin Q. Nguyen, Kathryn L. Humphreys, Yanbin Niu, Sophia Vinci-Booher, Carissa J. Cascio, The HABS-HD Study Team, Alzheimer’s Disease Neuroimaging Initiative, The BIOCARD Study Team, L. Taylor Davis, Zhiyuan Li, Simon N. Vandekar, Panpan Zhang, John Gore, Bennett A. Landman, Kurt G. Schilling. White matter micro- and macrostructure brain charts for the human lifespan. Nature (2026). https://doi.org/10.1038/s41586-026-10454-2.

Abstract: The human brain relies on a complex network of connections to function, with white matter (WM) acting as the primary communication highway between different brain regions. Disruptions in these critical communication pathways are linked to several neurological, psychiatric, and developmental disorders. While clinicians have long used standard growth charts to track physical development, with more recent work translating these to whole brain and gray matter measurements, there has been no equivalent reference standard for WM. Establishing a readily available normative reference is an imperative first step if we hope to utilize these WM structural biomarkers clinically. Here we present lifespan reference charts for human brain WM. By processing and standardizing 35,120 brain scans from diverse global studies, we mapped the typical growth, maturation, and age-related decline of specific brain pathways from birth through 100 years of age. These reference charts establish a fundamental benchmark for healthy brain development and aging, allowing researchers and clinicians to quantify how an individual’s brain deviates from typical patterns and highlighting disorder-related alterations. Furthermore, the accompanying open-access charts enable the scientific and clinical communities to evaluate new patient and research data against these normative baselines, facilitating future clinical and neuroscience studies.